Examining Factors Behind Racial Disparities In Breast, Colon Cancers

The following summarizes articles about two cancer studies that examine racial disparities.

* Breast cancer: Researchers from the University of North Carolina's Lineberger Comprehensive Cancer Center are expanding the Carolina Breast Cancer Study to examine why black women are more likely than white women to die from the disease, the Raleigh News & Observer reports.

read more

Continue reading ...

To coincide with World Diabetes Day, a Diabetes UK volunteer has today launched a new messageboard website. Diabetes Support talking blood sugars will allow people with diabetes to exchange knowledge and experiences with other people with the condition, their family and carers. Continue reading ...

Data from a new global survey released on World Diabetes Day finds that many teens and young adults with type 1 diabetes are optimistic about their future, but report a lack of support from school staff. The poll highlights the importance of family and peer-to-peer support.

read more

Continue reading ...

Nursing home operator Extendicare faces a third class action suit, this time filed on behalf of all residents of their nursing homes in Wisconsin. Similar Extendicare class action lawsuits have been filed in Washington and Minnesota, with all of the cases alleging that the company places profits over patient care by admitting residents that they are not properly equipped to handle.

read more

Continue reading ...

The following is a summary of efforts and grants that seek to reduce racial and ethnic health disparities. Alaska Native Tribal Health Consortium: The Continue reading ...

The 128 new HIV/AIDS cases recorded between the beginning of 2008 and the end of October in the Czech Republic have broken a record for the highest number of new cases registered in the country, Jana Vandasova of the National Reference Laboratory for AIDS said on Thursday, the CTK/Prague Daily Monitor reports.

According to Vandasova, there were 122 new cases registered last year, and the National Reference Laboratory for AIDS said this year represents the largest growth in HIV/AIDS cases since the mid-1980s, when the country began testing for the virus.

read more

Continue reading ...

Biodel Inc. (Nasdaq: BIOD) today reported positive effects of VIAject™ insulin on microvascular function in patients with Type 2 diabetes which were superior to results seen with regular human insulin and insulin lispro. Professor Thomas Forst, MD, Institute for Clinical Research and Development (IKFE), Mainz, Germany, and principal investigator of the study, presented the findings today at the Eighth Annual Diabetes Technology Meeting in Bethesda, MD. Continue reading ...

Heartburn - Natural Cures and Remedies

Heartburn can be one of the most uncomfortable, and sometimes painful sensations, and frequently occurs among people of all ages. There are several causes for it, some of which can be eliminated through proper diet or treatment of other ailments that are closely associated with it. There are several medications on the market that are designed to treat and cure heartburn, but, as with many other conditions, there are natural remedies that may be helpful and found in your own kitchen cabinet.

Plymouth Hospitals To Lead Cancer Surgery Training Programme, England

Plymouth Hospitals NHS Trust has been chosen to co-ordinate the national programme for the training of existing consultants in advanced keyhole surgery for the treatment of bowel cancer. The Department of Health has appointed Consultant General Surgeon, Mr Mark Coleman as the National Clinical Lead for the Laparoscopic Colorectal Cancer Surgery Training Programme. Continue reading ...

Teens continue to put themselves at unnecessary risk of skin cancer by spending excessive time in the sun and forgetting to protect themselves, according to new Cancer Council research. Findings from the Cancer Council's National Sun Protection Survey released today show teens spend an average of two hours (1hr 51mins) in the sun during peak UV, with almost a third who get sunburnt saying they "forgot" to protect themselves. Continue reading ...

Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has progressed another of its oncology compounds into pivotal phase III clinical development. Continue reading ...

In the November 15th issue of G&D, Dr. Kenneth Dorshkind and colleagues at the David Geffen School of Medicine (UCLA) have identified two genes - p16(Ink4a) and Arf - that sensitize lymphoid progenitor cells to the effects of aging, and confer resistance to leukemogenesis. Hematopoiesis (the development of blood cells) entails two main pathways: myelopoiesis (the formation of the red and white myeloid cells) and lymphopoiesis (the formation of B- and T-cells). Continue reading ...

Cytopia Limited (ASX:CYT) has commenced dosing patients in its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, to treat glioblastoma multiforme (GBM), an aggressive brain cancer. The GBM clinical trial is the company's first Phase II efficacy study in highly vascular, solid tumour indications and the first time CYT997 is being investigated in a tumour of the central nervous system. Continue reading ...

A new piece of medical technology unveiled at the National Physical Laboratory (NPL) will help improve the success rates of radiotherapy cancer treatments. The new clinical electron linear accelerator (linac) will help ensure patients are treated with accurate doses of radiation. Radiotherapy treats cancer, by using ionising radiation such as high-energy X-rays or electron beams, to destroy cancer cells. Continue reading ...

Propelled by advances in molecular biology, the treatment of colorectal cancer is on the verge of dramatic change and a promising future as innovative vaccines will replace chemotherapy. According to a new report from Kalorama Information, "Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis," this market, lead by OncoVAX, is poised for unprecedented growth, creating countless opportunities for market participants. Continue reading ...